According to the opening of an industrial business announcement, the wholly-owned subsidiary Shanghai Lei Yunshang Pharmaceutical West District Co., Ltd. plans to use its own capital to acquire 60% of the shares of Lacey Lean, which are minority shareholders of its holding subsidiaries Shanghai Lacey Lean Supply Chain Management Co., Ltd., and Shanghai Wanxu Health Technology Co., Ltd., which are minority shareholders of Shanghai Lacey Lean Supply Chain Management Co., Ltd., through a private agreement. The final price of this transaction will be based on the official evaluation price after the state-owned assets filing is completed. The three shareholders will negotiate to determine the final price, and not exceed the official evaluation of the corresponding value after the state-owned assets filing. Using December 31, 2025 as the evaluation reference date, the preliminary estimated price is approximately RMB 47.39 million based on the pre-assessed price corresponding to 60% of the shares. After the transaction is completed, Lacey's shareholding ratio in Lacey Lean will increase from 40% to 100%, and there will be no change in the scope of the company's consolidated statements.

According to the opening of an industrial business announcement, the wholly-owned subsidiary Shanghai Lei Yunshang Pharmaceutical West District Co., Ltd. plans to use its own capital to acquire 60% of the shares of Lacey Lean, which are minority shareholders of its holding subsidiaries Shanghai Lacey Lean Supply Chain Management Co., Ltd., and Shanghai Wanxu Health Technology Co., Ltd., which are minority shareholders of Shanghai Lacey Lean Supply Chain Management Co., Ltd., through a private agreement. The final price of this transaction will be based on the official evaluation price after the state-owned assets filing is completed. The three shareholders will negotiate to determine the final price, and not exceed the official evaluation of the corresponding value after the state-owned assets filing. Using December 31, 2025 as the evaluation reference date, the preliminary estimated price is approximately RMB 47.39 million based on the pre-assessed price corresponding to 60% of the shares. After the transaction is completed, Lacey's shareholding ratio in Lacey Lean will increase from 40% to 100%, and there will be no change in the scope of the company's consolidated statements.